lacrimal-gland 发表于 2025-3-23 10:35:53

http://reply.papertrans.cn/1/5/414/414-11.png

光滑 发表于 2025-3-23 15:47:18

Submitted on: 13 May 2005.
Revised on: 10 June 2005.
Accepted on: 02 August 2005.

___________________ACTA ONCOLOGICA---TAYLOR & FRANCIS LTD

发源 发表于 2025-3-23 18:42:20

Submitted on: 16 February 2000.
Revised on: 09 April 2000.
Accepted on: 29 May 2000.

___________________ACTA ONCOLOGICA---TAYLOR & FRANCIS LTD

远足 发表于 2025-3-24 00:06:06

Submitted on: 18 April 2021.
Revised on: 05 August 2021.
Accepted on: 13 September 2021.

___________________ACTA ONCOLOGICA---TAYLOR & FRANCIS LTD

ticlopidine 发表于 2025-3-24 05:00:16

Submitted on: 06 March 2003.
Revised on: 23 April 2003.
Accepted on: 18 June 2003.

___________________ACTA ONCOLOGICA---TAYLOR & FRANCIS LTD

尖叫 发表于 2025-3-24 07:01:58

Submitted on: 03 December 2017.
Revised on: 14 March 2018.
Accepted on: 07 May 2018.

___________________ACTA ONCOLOGICA---TAYLOR & FRANCIS LTD

nuclear-tests 发表于 2025-3-24 12:36:03

http://reply.papertrans.cn/1/5/414/414-17.png

致敬 发表于 2025-3-24 17:49:26

http://reply.papertrans.cn/1/5/414/414-18.png

GUMP 发表于 2025-3-24 21:52:01

Submitted on: 12 August 2018.
Revised on: 06 October 2018.
Accepted on: 24 November 2018.

___________________ACTA ONCOLOGICA---TAYLOR & FRANCIS LTD

艰苦地移动 发表于 2025-3-24 23:15:35

Submitted on: 17 July 2006.
Revised on: 18 September 2006.
Accepted on: 16 November 2006.

___________________ACTA ONCOLOGICA---TAYLOR & FRANCIS LTD
页: 1 [2] 3 4
查看完整版本: SCIE期刊ACTA ONCOLOGICA 2024/2025影响因子:2.779 (ACTA ONCOL) (0284-186X). (ONCOLOGY)(肿瘤学)Science Citation Index Expanded